SENSICARDIAC vs Zio AT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 68/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
SENSICARDIAC
by Diacoustic Medical Devices (Pty) Ltd.
VS
Zio AT ECG Monitoring System
by iRhythm Technologies, Inc.

AI Verdict

SENSICARDIAC focuses on real-time AI-powered heart murmur detection using electronic stethoscopes to classify murmurs as pathological or physiological. In contrast, the Zio AT ECG Monitoring System provides continuous, long-term AI-powered ECG monitoring via a wearable patch for arrhythmia detection. While both leverage AI for remote cardiac diagnostics and fall under cardiology, they address distinct cardiac conditions and employ different data acquisition methods.

Choose SENSICARDIAC if…

Choose SENSICARDIAC if your primary need is real-time, AI-assisted heart murmur detection and classification during a patient examination, either in-person or via telehealth. This tool excels at quickly differentiating between pathological and physiological murmurs using electronic stethoscopes, aiming to reduce unnecessary specialist referrals.

View SENSICARDIAC →

Choose Zio AT ECG Monitoring System if…

Choose the Zio AT ECG Monitoring System if you require continuous, long-term ECG monitoring for up to 14 days to detect intermittent or asymptomatic arrhythmias. This wearable solution is ideal for capturing elusive cardiac events that may not be present during a standard office visit, providing comprehensive data for arrhythmia diagnosis.

View Zio AT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature SENSICARDIAC Zio AT ECG Monitoring System
Pricing Unknown Contact for pricing
Deployment SensiCardiac is a software package running on a Windows PC that interfaces with compatible electronic stethoscopes. SensiCardiac Mobi runs on a mobile device (iPhone 4S or later) and interfaces with a hosted Linux server environment. The related Telesensi platform operates entirely in the browser. Cloud-based (data analytics and clinician portal)
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio AT ECG Monitoring System

Tool B (Zio AT) offers a highly user-friendly 'wear and forget' patch for patients, simplifying long-term monitoring with easy application and symptom logging via a mobile app. Its comprehensive ZioSuite clinician portal streamlines workflows for remote patient registration, ordering, and report interpretation. While Tool A (SENSICARDIAC) provides guided real-time auscultation and detailed reports for physicians during an exam, Tool B's broader approach to patient convenience and clinician workflow efficiency across the monitoring continuum gives it an edge.

Clinical Value

Zio AT ECG Monitoring System

Tool B (Zio AT) demonstrates superior clinical value through its ability to provide continuous, uninterrupted ECG monitoring for up to 14 days, significantly increasing the detection rate of both symptomatic and asymptomatic arrhythmias compared to shorter-duration monitors. This leads to a higher diagnostic yield, reduced retesting, and improved clinical decision-making. While Tool A (SENSICARDIAC) offers accurate, AI-powered heart murmur detection, Tool B's comprehensive, long-term arrhythmia detection addresses a broader and often more elusive set of cardiac conditions with extensive clinical validation.

Pricing & Value

Tie

Both Tool A (SENSICARDIAC) and Tool B (Zio AT) state 'contact for pricing' and do not publicly disclose their pricing models or detailed cost structures. Without transparent pricing information or comparative cost-effectiveness studies, it is impossible to accurately assess which tool offers better value for money. Therefore, a definitive winner cannot be determined in this dimension.

Enterprise Readiness

Zio AT ECG Monitoring System

Tool B (Zio AT) exhibits stronger enterprise readiness with explicit mentions of EHR integration, including specific integration with athenahealth, which streamlines ordering and reporting workflows within existing healthcare IT systems. It also provides a robust cloud-based clinician portal and mobile app for remote care and patient management. While Tool A (SENSICARDIAC) offers cloud deployment, desktop options, and mentions white-labeling for integrators, Tool B's demonstrated integration capabilities and comprehensive system for managing a patient's monitoring journey are more indicative of readiness for large-scale enterprise adoption.

Innovation

Zio AT ECG Monitoring System

Tool B (Zio AT) is more innovative due to its 'wear and forget' patch design for continuous, long-term (up to 14 days) ECG recording, which significantly surpasses traditional Holter monitoring capabilities for detecting transient arrhythmias. Its FDA-cleared deep-learned AI algorithm for comprehensive arrhythmia detection, including asymptomatic events, represents a substantial advancement in passive cardiac monitoring. While Tool A (SENSICARDIAC) offers innovative real-time, AI-assisted auscultation with out-of-band audio streaming for telehealth, Tool B's novel form factor and extended, comprehensive diagnostic capability for arrhythmias address a more challenging and impactful clinical need.

Support & Docs

Zio AT ECG Monitoring System

Tool B (Zio AT) provides more comprehensive and readily accessible support and documentation, including a 24/7 customer care phone number, detailed Instructions for Use, Clinical Reference Manuals, and dedicated patient support FAQs. While Tool A (SENSICARDIAC) offers user manuals and mentions integration support, Tool B's extensive and easily discoverable resources for both clinicians and patients demonstrate a more robust and transparent support infrastructure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature SENSICARDIAC Zio AT ECG Monitoring System
Name SENSICARDIAC Zio AT ECG Monitoring System
Company DIACOUSTIC MEDICAL (PTY) iRhythm Technologies, Inc.
Primary Function / Key AI Use AI-powered heart murmur detection and classification (pathological/physiological) AI-powered ECG monitoring for long-term arrhythmia detection
Data Collection Method Integration with electronic stethoscopes (e.g., 3M Littmannu00ae 3200) Wearable Zio AT patch for continuous ECG recording
Monitoring Duration Real-time analysis Continuous, uninterrupted ECG recording for up to 14 days
Output/Reporting Detailed cardiac reports (downloadable PDFs, visualization, S1/S2 indicators) Comprehensive end-of-wear reports for clinicians, ZioSuiteu00ae clinician portal
Target Condition Heart murmurs Arrhythmias

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC and Zio AT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

SENSICARDIAC is designed for real-time heart murmur detection during an office visit, classifying murmurs as pathological or physiological to aid in immediate diagnosis and potentially reduce unnecessary referrals. Zio AT, conversely, focuses on continuous, long-term ECG monitoring for up to 14 days to detect symptomatic and asymptomatic arrhythmias, providing comprehensive end-of-wear reports for later review and management of electrical heart conditions.
SENSICARDIAC's AI analyzes heart sounds against a large validated database of pathological murmurs, with reported accuracy above 95 percent, classifying them as dangerous pathological (Class I) or innocent physiological (Class III). Zio AT utilizes an FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection, with studies showing high diagnostic yield and 99% physician agreement with end-of-wear reports, which can lead to more accurate and timely diagnoses.
SENSICARDIAC provides detailed cardiac reports as downloadable PDFs, which can be manually uploaded or attached to EHRs. Zio AT offers more robust EHR integration services, allowing for patient registration, report reception, and ordering of monitors directly through the EHR, compatible with major systems like Epic via the Aura network, though daily and transmission reports may be available only in ZioSuite.
SENSICARDIAC features a guided auscultation process and real-time analysis, suggesting a relatively straightforward learning curve for physicians already proficient with stethoscopes. Zio AT involves patient application of a wearable patch and clinician use of a portal for report interpretation, with studies indicating that Zio XT (a previous generation device) can lead to significant reductions in outpatient appointments and time spent on rhythm analysis, suggesting a quick time-to-value for arrhythmia detection.
iRhythm Technologies (Zio AT) highlights that the value of its service has been demonstrated in over 100 original scientific research manuscripts and multiple real-world studies, such as CAMELOT and AVALON, reinforcing its clinical superiority and diagnostic yield. SENSICARDIAC's description mentions analysis against a large validated database and collaborations for its roadmap, but does not explicitly detail customer references or the scope of ongoing support.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring SENSICARDIAC or Zio AT ECG Monitoring System

Backers

Who funded each tool's parent company.

Zio AT ECG Monitoring System

AI Tool Finder
AI-powered search. Results may not be comprehensive.